Morgan Stanley's profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record.

If the rise of Donald Trump has taught us anything about politics, it’s to expect the unexpected – but with his second term as President just a

Morgan Stanley assigned a new analyst to cover hot artificial intelligence stock Palantir Technologies, and the Wall Street firm joined the ranks forecasting worse times ahead for the stock.

Vir Biotechnology's Phase 1 data highlights early promise for T-cell engagers targeting HER2-positive tumors and prostate cancer with manageable safety.

Key Takeaways Major U.S. indexes were little changed at midday Thursday after Wednesday's big gains powered by strong bank earnings and a softer-than-expected inflation report.Morgan Stanley shares gained after the financial firm topped earnings and revenue estimates.

Morgan Stanley’s fourth-quarter profit more than doubled, boosted by trading revenue that came in well ahead of estimates on volatility tied to the US elections.

Morgan Stanley (NYSE:MS) analysts issued an update on iQIYI shares (NASDAQ:IQ), reducing the price target from $2.40 to $2.20, while maintaining an Equalweight rating on the stock. The adjustment follows their projection of a revenue decline and potential challenges in the company's subscription growth.